IP Library Granted Patent US 12,312,517
Granted Patent B2
US 12,312,517 · App. 17/612,375 · Granted May 27, 2025

Adhesive compositions

Inventors: Ying Zhang (Woodbury, MN); Robert A. Asmus (Hudson, WI); Zhicheng Tian (Woodbury, MN); Kheng Vang (St. Paul, MN); James Dizio (St. Paul, MN); Patrick J. Parks (St. Paul, MN); Brian E. Spiewak (Inver Grove Heights, MN)
Assignee: Solventum Intellectual Properties Company
C09J7/385A61L15/585A61L24/043A61L31/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,312,517
App. No.
17/612,375
Granted
May 27, 2025
Kind
B2
Abstract

Adhesive compositions are disclosed that include an octenidine salt, a resin system, a plasticizer, and a cidatrope. The dried adhesive compositions are substantially free of water and C 2 -C 5 alcohols. The adhesive compositions disclosed are formulations that provide rapid and persistent antimicrobial activity and may be useful, for example, in wound dressings, surgical drapes, and medical tapes.

Claims (30)

1. An adhesive composition comprising:

40 wt. % to 90 wt. % resin system, wherein the resin system is a pressure-sensitive adhesive comprising a polymer prepared from:

70 wt. % to 95 wt. % of a first monomer, wherein the first monomer is a low Tg acrylate monomer selected from the group consisting of iso-octyl acrylate, 2-ethyl hexyl acrylate, 2-octyl acrylate, and butyl acrylate;

1 wt. % to 25 wt. % of a second monomer, wherein the second monomer is a polar, non-acidic monomer selected from the group consisting of acrylamide, N-vinyl pyrrolidone, and hydroxyl alkyl acrylate; and

0 wt. % to 20 wt. % vinyl acetate or butyl vinyl ether;

0 wt. % to 59.49 wt. % plasticizer,

0.01 wt. % to 10 wt. % octenidine salt, and

0.5 wt. % to 59.99 wt. % cidatrope, the cidatrope selected from a C 8 -C 26 alcohol, a C 8 -C 26 ether, a C 8 -C 26 amide, a C 8 -C 26 ester, or a combination thereof;

water in an amount less than 1 wt %; and

C 2 -C 5 alcohol in an amount less than 1 wt %,

wherein wt % is based on the weight of the adhesive composition.

2. The adhesive composition of claim 1 , wherein the first monomer is iso-octyl acrylate and the second monomer is acrylamide.

3. The adhesive composition of claim 1 , wherein the polymer comprises vinyl acetate or butyl vinyl ether.

4. The adhesive composition of claim 1 , wherein the modulus of the pressure sensitive adhesive is 10,000 to 200,000 Pa at 25° C.

5. The adhesive composition of claim 1 , wherein the resin system is characterized by a modulus of 50,000 to 1,000,000 Pa at 25° C.

6. The adhesive composition of claim 1 , wherein the plasticizer is selected from the group consisting of glyceryl monoisostearate, glyceryl monooleate, decagylcerol hexaoleate, decagylcerol decaoleate, acetyltributyl citrate, and combinations thereof.

7. The adhesive composition of claim 1 , wherein the composition is a dried composition.

8. The adhesive composition of claim 1 , wherein the cidatrope and the octenidine salt are present in a weight percentage ratio of cidatrope:octenidine salt of 0.1:1 to 3000:1.

9. The adhesive composition of claim 1 , wherein the octenidine salt is selected from the group consisting of octenidine dihydrochloride, octenidine gluconate, octenidine sulfate, octenidine acetate, and combinations thereof.

10. The adhesive composition of claim 1 , wherein the plasticizer is glyceryl monoisostearate and the cidatrope is triethyl citrate.

11. The adhesive composition of claim 1 , wherein the cidatrope is a C 8 -C 26 alcohol selected from the group consisting of 1-tetradecanol, hexadecanol, 16-methyl-1-heptadecanol, and combinations thereof.

12. The adhesive composition of claim 1 , wherein the cidatrope is a C 8 -C 26 ether that is a propoxylated C 2 to C 18 alcohol having a degree of propoxylation of 2 to 50 moles per mole of alcohol.

13. The adhesive composition of claim 1 , wherein the cidatrope is a C 8 -C 26 amide is-selected from the group consisting of a coconut fatty acid monoethanol amide, a coconut fatty acid methyl ethanolamide, an alkyl alkanolamide, and a combinations thereof.

14. The adhesive composition of claim 1 , wherein the cidatrope is a C 8 -C 26 ester is selected from the group consisting of diisopropyl adipate, dibutyl sebacate, triethyl citrate, tributyl citrate, octyldodecyl neopentanoate, laureth-2-acetate, isopropyl myristate, trioctyldodecyl citrate, myristyl myristate, cetyl acetate, and a combinations thereof.

15. An article comprising:

a substrate, and

an adhesive composition according to claim 1 ,

wherein the adhesive composition contacts at least a portion of a surface of the substrate.

16. The article according to claim 15 , wherein the article is a medical article.

17. The article according to claim 16 , wherein the medical article is a self-adhesive dressing, a surgical drape, or a medical tape.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0149 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME "YANG" ZHANG SHOULD BE "YING" ZHANG PREVIOUSLY RECORDED AT REEL: 058152 FRAME: 0192. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 28, 2022
From: ZHANG, YING; ASMUS, ROBERT A.; TIAN, ZHICHENG; VANG, KHENG; DIZIO, JAMES; PARKS, PATRICK J.; SPIEWAK, BRIAN E.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 058893/0059 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR ZHANG, YANG TO ZHANG, YING PREVIOUSLY RECORDED ON REEL 058152 FRAME 0192. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTION.. Recorded Dec 2, 2021
From: ZHANG, YING
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 058906/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: ZHANG, YANG; ASMUS, ROBERT A.; TIAN, ZHICHENG; VANG, KHENG; DIZIO, JAMES; PARKS, PATRICK J.; SPIEWAK, BRIAN E.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 058152/0192 →
Continuity (2)
Provisional Application 62852730 · May 24, 2019
Related Publication 20220298389A1 · Sep 22, 2022
References Cited (15)
US 3645835A · Hodgson · 1972 [cited by applicant]
US 4595001A · Potter · 1986 [cited by applicant]
US 20100282409A1 · Hobbs · 2010 [cited by examiner]
US 20130231394A1 · Arndt · 2013 [cited by applicant]
US 20150328360A1 · Menon · 2015 [cited by examiner]
US 20190366067A1 · Ginggen · 2019 [cited by examiner]
EP 0375827A2 · 1990 [cited by applicant]
EP 3150234 · 2017 [cited by applicant]
JP 11349418A · 1999 [cited by applicant]
WO WO2009088894 · 2009 [cited by applicant]
WO WO2014035981A1 · 2014 [cited by applicant]
Dettenkofer, Skin Disinfection with Octenidine Hydrochloride for Central Venous Catheter Site Care: A Double-Blind Randomized, Controlled Trial, Clin Microbiol Infect 2010, vol. 16, pp. 600-606. [cited by applicant]
Loveday, “epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England”, Journal of Hospital Infections 86S1, 2014, pp. S1-S70. [cited by applicant]
Silvestri, “Chlorhexidine: Uses and Adverse Reactions”, Dermatitis, 2013, vol. 24, No. 3, pp. 112-118. [cited by applicant]
International Search Report for PCT International Application No. PCT/IB2020/054704, mailed on Aug. 24, 2020, 4 pages. [cited by applicant]